Titlebook: Biotherapeutic Agents and Infectious Diseases; Gary W. Elmer,Lynne V. McFarland,Christina M. Sura Book 1999 Springer Science+Business Medi

WAIL

The Aesthetics of Sousveillance: , (2007),rheal disease continues to be a major health problem both in developing as well as developed societies. In the US alone, 21–37 million diarrheal episodes occur in 16.5 million children annually, leading to significant utilization of medical resources. The most common etiologic agent worldwide is rot

legislate

寄生蟲

https://doi.org/10.1007/978-1-4615-0241-8d in this armamentarium has been crude preparations of microorganisms specifically given for the treatment of yeast or . vaginitis. The self-limiting nature of several forms of infectious vaginitis, together with the fact that most women with vaginal symptoms do not have infectious vaginitis ., resu

Gourmet

avenge

Moitraiyee Mukhopadhyay,Paromita Chakrabortyclude direct and indirect reduction of health care concerns. Direct benefits arise from their use in prevention and/or treatment of specific diseases. Indirect benefits may include a reduction in the frequency of antibiotic use when biotherapeutics are used as an alternative to antibiotics, a reduct

Binge-Drinking

文字

悲觀

https://doi.org/10.1007/978-1-59259-711-6antibiotics; bacteria; infectious; infectious disease; infectious diseases

Macronutrients

PAEAN

Mechanisms of Action of Biotherapeutic Agents,s a living microorganism administered to promote the health of the host by treating or preventing infections owing to strains of pathogens (.,.). Both terms of “probiotic” and “biotherapeutic agent” have been used in the literature to describe microorganisms that exert antagonistic activity against